Monitor for the appointment of a new principal accounting officer. The departure is routine and does not signal operational issues, but a prolonged vacancy could raise minor concerns about financial reporting continuity.
IMA drugs
IMA drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Jun 29 $6.07entry
- T+1 · 5mo ago −2.80%α −3.58% · $5.90
- T+5 · 4mo ago −1.15%α −2.54% · $6.00
- T+20 · 4mo ago −7.91%α −7.63% · $5.59
- T+60 · 8w ago −20.10%α −24.48% · $4.85
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
ImageneBio disclosed the resignation of Robert Lally, SVP of Finance and Operations and principal accounting officer, effective July 22, 2026. The resignation is not due to any disagreement, and the company plans to search for a replacement. This is a routine officer departure with no immediate financial impact.
Key Facts
- Robert Lally, SVP of Finance and Operations and principal accounting officer, resigned effective July 22, 2026.
- Resignation was not due to any disagreement with the company.
- No replacement named; company will conduct a search.
Financial Impact
No direct financial impact from this filing.
Risk Factors
- Potential disruption in financial reporting if replacement is not found promptly.
- Minor distraction for management during the search process.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-285424 |
| Document: 0001193125-26-285424-index-headers.html | 0001193125-26-285424 |
| Document: 0001193125-26-285424-index.html | 0001193125-26-285424 |
| Document: 0001193125-26-285424.txt | 0001193125-26-285424 |
Track record
10 reports on IMA
3 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +27.94% at T+60 after the Aug 7, 2026 report. 3 of 3 went positive at some point.
Filters
- Nov 13, 20263d ago SC 13G/A Neutral 2/10 Entry $3.50 Now $3.20 −8.57% settles Feb 12
- Nov 9, 20267d ago 8-K Neutral 4/10 Entry $3.81 Now $3.20 −16.01% settles Feb 8
- Aug 7, 202614w ago EFFECT Bearish 5/10 Entry $5.69 to $4.10 Now $3.20 +43.76% ▲ +27.94% +25.81% vs SPY
- Jun 26, 202620w ago 8-K Neutral 3/10 Viewing Entry $6.07 to $4.85 Now $3.20 −47.28% ▼ −20.10% −24.48% vs SPY
- Apr 30, 202628w ago DEFA14A Neutral 3/10 Entry $5.66 to $5.76 Now $3.20 −43.46% ▲ +1.77% −1.30% vs SPY
- Apr 13, 202631w ago 8-K Bearish 6/10 Entry $6.05 to $5.93 Now $3.20 +47.11% ▲ +2.07% +10.99% vs SPY
- Apr 13, 202631w ago Press Release Bearish 6/10 Entry $6.05 to $5.93 Now $3.20 +47.11% ▲ +2.07% +10.99% vs SPY
- Apr 6, 202632w ago EFFECT Neutral 3/10 Entry $4.55 to $5.77 Now $3.20 −29.67% ▲ +26.81% +13.34% vs SPY
- Mar 17, 202634w ago Press Release Neutral 3/10 Entry $5.83 to $5.71 Now $3.20 −45.06% ▼ −1.97% −13.50% vs SPY
- Mar 10, 202635w ago Press Release Neutral 4/10 Entry $6.07 to $5.45 Now $3.20 −47.28% ▼ −10.21% −21.90% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers